Evidence map›Paper›PMID 29429955›Full record

ArticleTuberculosis (Edinburgh, Scotland)2018

Corrigendum to "Mechanisms of resistance against NITD-916, a direct inhibitor of Mycobacterium tuberculosis InhA" [Tuberculosis 107 (December 2017) 133-136].

Matthew B McNeil, Devon Dennison, Catherine Shelton, Lindsay Flint, Aaron Korkegian, Tanya Parish

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Matthew B McNeilTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA.
Devon DennisonTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA.
Catherine SheltonTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA.
Lindsay FlintTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA.
Aaron KorkegianTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA.
Tanya ParishTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA. Electronic address: tanya.parish@idri.org.
Infectious Disease Research Institute · US

Funding

Chemical probes of vulnerable pathways in antibiotic-resistant pathogensR01AI099188 · NIAID · ACCESS TO ADVANCED HEALTH INSTITUTE · PI PARISH, TANYA · 2012 to 2016
$3.7M
NIAID NIH HHS R01 AI099188
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29429955
OpenAlexW2789823580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.